BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 38742709)

  • 1. Bone marrow mesenchymal stromal cells support regeneration of intestinal damage in a colitis mouse model, independent of their CXCR4 expression.
    Pervin B; Gizer M; Şeker ME; Erol ÖD; Gür SN; Polat EG; Değirmenci B; Korkusuz P; Aerts-Kaya F
    Clin Transl Sci; 2024 May; 17(5):e13821. PubMed ID: 38742709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Phylogenetic Analysis of
    Naheed F; Mumtaz R; Shabbir S; Jamil A; Asif AR; Rahman A; Ahmad HI; Essa M; Akhtar H; Mahmoud SF; Alghamdi FO; Amari HAA; Chen J
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells.
    Liu J; Lai X; Bao Y; Xie W; Li Z; Chen J; Li G; Wang T; Huang W; Ma Y; Shi J; Zhao E; Xiang AP; Liu Q; Chen X
    Front Immunol; 2022; 13():853894. PubMed ID: 35371051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Inflammatory Bowel Disease: A Comprehensive Review.
    Cai Z; Wang S; Li J
    Front Med (Lausanne); 2021; 8():765474. PubMed ID: 34988090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review.
    Sanchez-Diaz M; Quiñones-Vico MI; Sanabria de la Torre R; Montero-Vílchez T; Sierra-Sánchez A; Molina-Leyva A; Arias-Santiago S
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34210026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells.
    Cuesta-Gomez N; Graham GJ; Campbell JDM
    J Transl Med; 2021 Apr; 19(1):156. PubMed ID: 33865426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 expression by mesenchymal stromal cells is lost after use of enzymatic dissociation agents, but preserved by use of non-enzymatic methods.
    Pervin B; Aydın G; Visser T; Uçkan-Çetinkaya D; Aerts-Kaya FSF
    Int J Hematol; 2021 Jan; 113(1):5-9. PubMed ID: 33389659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration.
    Bianchi ME; Mezzapelle R
    Front Immunol; 2020; 11():2109. PubMed ID: 32983169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.
    Stephens BS; Ngo T; Kufareva I; Handel TM
    Sci Signal; 2020 Jul; 13(640):. PubMed ID: 32665413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Chemokine CCL28 in Ulcerative Colitis Patients.
    Lee DS; Lee KL; Jeong JB; Shin S; Kim SH; Kim JW
    Gut Liver; 2021 Jan; 15(1):70-76. PubMed ID: 32102131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments for inflammatory bowel disease.
    Hazel K; O'Connor A
    Ther Adv Chronic Dis; 2020; 11():2040622319899297. PubMed ID: 32076497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease.
    Martinez-Fierro ML; Garza-Veloz I; Rocha-Pizaña MR; Cardenas-Vargas E; Cid-Baez MA; Trejo-Vazquez F; Flores-Morales V; Villela-Ramirez GA; Delgado-Enciso I; Rodriguez-Sanchez IP; Ortiz-Castro Y
    Medicine (Baltimore); 2019 Sep; 98(38):e17208. PubMed ID: 31567972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis.
    Boshagh MA; Foroutan P; Moloudi MR; Fakhari S; Malakouti P; Nikkhoo B; Jalili A
    J Inflamm Res; 2019; 12():167-174. PubMed ID: 31417300
    [No Abstract]   [Full Text] [Related]  

  • 14. SDF-1/CXCR4 axis enhances the immunomodulation of human endometrial regenerative cells in alleviating experimental colitis.
    Li X; Lan X; Zhao Y; Wang G; Shi G; Li H; Hu Y; Xu X; Zhang B; Ye K; Gu X; Du C; Wang H
    Stem Cell Res Ther; 2019 Jul; 10(1):204. PubMed ID: 31286993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.
    Noronha NC; Mizukami A; Caliári-Oliveira C; Cominal JG; Rocha JLM; Covas DT; Swiech K; Malmegrim KCR
    Stem Cell Res Ther; 2019 May; 10(1):131. PubMed ID: 31046833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived CXCR4-overexpressing MSCs display increased homing to intestine and ameliorate colitis-associated tumorigenesis in mice.
    Zheng XB; He XW; Zhang LJ; Qin HB; Lin XT; Liu XH; Zhou C; Liu HS; Hu T; Cheng HC; He XS; Wu XR; Chen YF; Ke J; Wu XJ; Lan P
    Gastroenterol Rep (Oxf); 2019 Apr; 7(2):127-138. PubMed ID: 30976426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CXCR7 promotes mesenchymal stem cells to repair phosgene-induced acute lung injury in rats.
    Shao Y; Zhou F; He D; Zhang L; Shen J
    Biomed Pharmacother; 2019 Jan; 109():1233-1239. PubMed ID: 30551373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells and CXC chemokine receptor 4 overexpression improved the therapeutic effect on colitis via mucosa repair.
    Chen Z; Chen Q; Du H; Xu L; Wan J
    Exp Ther Med; 2018 Aug; 16(2):821-829. PubMed ID: 30112037
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.